Carrie joined Health Advances in 2007 and leads the firm’s Orphan Disease Practice.
At Health Advances, Carrie works towards the advancement of novel therapeutics, drawing from experience across commercialization and development strategies and benchmarking, new product planning, and market assessment & forecasting.
Her clients have ranged from small start-ups and university technology transfer offices to the largest biopharmaceutical companies and private equity firms. With experience across multiple therapeutic areas, she is particularly interested in specialty markets including orphan, ophthalmology, metabolic, and respiratory diseases.
Prior to joining Health Advances, Carrie received her MS degree in organic chemistry from Massachusetts Institute of Technology, and she worked for several years as a medicinal chemist at Merck & Co., Inc. in Rahway, New Jersey where she developed her interests in drug discovery and development.
Carrie received a BA in chemistry from Williams College.
At Health Advances, Carrie works towards the advancement of novel therapeutics, drawing from experience across commercialization and development strategies and benchmarking, new product planning, and market assessment & forecasting.
Her clients have ranged from small start-ups and university technology transfer offices to the largest biopharmaceutical companies and private equity firms. With experience across multiple therapeutic areas, she is particularly interested in specialty markets including orphan, ophthalmology, metabolic, and respiratory diseases.
Prior to joining Health Advances, Carrie received her MS degree in organic chemistry from Massachusetts Institute of Technology, and she worked for several years as a medicinal chemist at Merck & Co., Inc. in Rahway, New Jersey where she developed her interests in drug discovery and development.
Carrie received a BA in chemistry from Williams College.
Speaking In
2:15 PM - 3:15 PM
Monday, June 5
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
